ACHIEVE LIFE SCIENCES INC (ACHV)       6.76  +0.15 (+2.27%)

6.76  +0.15 (+2.27%)

US0044685008 - Common Stock - After market: 6.91 +0.15 (+2.22%)

ACHIEVE LIFE SCIENCES INC6.76

NASDAQ:ACHV (5/27/2022, 10:36:54 AM)+0.15 (+2.27%)

After market: 6.91 +0.15 (+2.22%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 05-12 2022-05-12/amc Earnings (Next) 08-10 2022-08-10
Ins Owners 0.33% Inst Owners 20.32%
Market Cap 65.44M Shares 9.68M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 84.62
IPO 10-12 1995-10-12

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ACHV Daily chart

Company Profile

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. The company is headquartered in Seattle, Washington and currently employs 16 full-time employees. The firm is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring plant-based alkaloid from the seeds of the Laburnum anagyroides plant. Cytisinicline is structurally similar to nicotine and a mechanism of action that is both agonistic and antagonistic. The firm is aid in smoking cessation, or nicotine addiction, by interacting with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms through agonistic effects on nicotine receptors and by reducing the reward and satisfaction associated with nicotine through antagonistic properties. The Company’s has two prescription oral treatments for smoking cessation are available in the United States: Chantix (varenicline) and Zyban (bupropion).

Company Info

ACHIEVE LIFE SCIENCES INC

22722 29Th Dr. Se, Suite 100

Seattle WASHINGTON V6E 4H1

P: 14256861500.0

CEO: John Bencich

Employees: 16

Website: http://achievelifesciences.com/

News

News Imagea day ago - Achieve Life SciencesAchieve Life Sciences Announces Participation at LD Micro Invitational Conference

SEATTLE and VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical...

News Image11 days ago - MicroCap Rodeo36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The Spring into Action: VIRTUAL begins on Monday, May 16th, 2022, with a Biotech Discovery Day. Company presentations begin at 1:30 PM Eastern Time. Presentations will be

News Image14 days ago - Achieve Life SciencesAchieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference

SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical...

News Image15 days ago - Achieve Life SciencesAchieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update

Company to host conference call at 4:30 PM EDT today, May 12, 2022...

News Imagea month ago - Achieve Life SciencesAchieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022

SEATTLE and VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical...

ACHV Twits

Here you can normally see the latest stock twits on ACHV, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example